Major Funding Grants
Major Funding Grants
$
Total Value
$
Average Grant
About Major Funding
These grants are valued at $1 million or more, representing significant government investments. They often fund large-scale research projects, infrastructure development, or major business initiatives.
Advanced Search & Filter Major Funding
Invest Ottawa (2013) Ottawa, ON
The objective of the project is to build an integrated incubation and acceleration program, which will provide high potential SMEs from Eastern Ontario with a graduated pathway to market. The project…
Canada Accelerator and Incubator Program 2018-19
$10,045,559
Enablement of SMB omni channel advertisement platform
ILLUMIN INC. Toronto, ON
Research and development of an omni-channel advertising platform and internal business processes designed specifically to address the advertising needs of SMBs
Industrial Research Assistance Program Contribut… 2023-24 April 1, 2023 - Dec. 31, 2024
$10,000,000
Entos Pharmaceuticals Inc. Edmonton, AB
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 infection by SARS-CoV-2. In this project, Entos will advance the VAX-001-1c biv…
Industrial Research Assistance Program Contribut… 2023-24 Sept. 1, 2022 - March 31, 2024
$10,000,000
Hybrid Integration Platform
Solace Corporation Ottawa, ON
A project to create an event-enabled, edge-supporting, integration and API management platform that supports modern, real-time, distributed, decoupled applications.
Industrial Research Assistance Program Contribut… 2023-24 May 1, 2023 - April 30, 2026
$10,000,000
Laurent Pharmaceuticals Inc. Montreal, QC
Clinical development of LAU-7b antiviral and inflammation-controlling therapy for COVID-19 infection.
Industrial Research Assistance Program Contribut… 2021-22 Oct. 1, 2020 - Dec. 31, 2022
$10,000,000
Entos Pharmaceuticals Inc. Edmonton, AB
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 infection by SARS-CoV-2. In this project, Entos will advance the VAX-001 vaccin…
Industrial Research Assistance Program Contribut… 2021-22 Sept. 1, 2020 - Aug. 31, 2021
$10,000,000
Entos Pharmaceuticals Inc. Edmonton, AB
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 infection by SARS-CoV-2. In this project, Entos will advance the VAX-001 vaccin…
Industrial Research Assistance Program Contribut… 2021-22 Sept. 1, 2020 - July 31, 2021
$10,000,000
Macrodyne Technologies Inc. Concord, ON
Development of advanced superplastic forming technology which uses Gas Oscillation to drastically (up to 10x) increase the speed of forming, moving SPF technology from a niche to forming technology …
Industrial Research Assistance Program – Contribu… 2024-25 May 1, 2024 - March 31, 2027
$10,000,000
Providence COVID-19 Vaccine Development - Stage 2
Providence Therapeutics Holdings Inc. Calgary, AB
The Firm is Canada's leader in mRNA therapeutics and this project's main goal is to continue the development of PTX-COVID19-B by conducting a Phase II clinical trial with the goal of commercializing …
Industrial Research Assistance Program Contribut… 2021-22 July 23, 2021 - Nov. 30, 2022
$8,660,000
Providence COVID-19 Vaccine Development - Stage 2
Providence Therapeutics Holdings Inc. Calgary, AB
The Firm is Canada's leader in mRNA therapeutics and this project's main goal is to continue the development of PTX-COVID19-B by conducting a Phase II clinical trial with the goal of commercializing …
Industrial Research Assistance Program Contribut… 2021-22 July 23, 2021 - Nov. 30, 2022
$8,600,000
Deploy & Operate
Vention inc. Montreal, QC
Build & Operate will create the software necessary to automate production using a number of third-party collaborative robots on manufacturing floors, including those of Fanuc, Doosan, Universal Robot…
Industrial Research Assistance Program Contribut… 2023-24 May 1, 2022 - May 31, 2024
$7,700,000
NORTHERN RNA INC. Calgary, AB
The COVID-19 pandemic has impacted the global supply of nucleic acid products including mRNA and plasmid DNA and delivery vehicles such as lipid nanoparticles which have been demonstrated to be impor…
Industrial Research Assistance Program Contribut… 2023-24 July 28, 2022 - March 22, 2024
$7,000,000
Laurent Pharmaceuticals Inc. Montreal, QC
#######################################################################################################################################################################################################…
Industrial Research Assistance Program – Contribu… 2024-25 Feb. 1, 2023 - March 31, 2025
$7,000,000
Introhive Services Inc. Fredericton, NB
Design and development to accelerate innovation and leverage AI, for transformative expansion of Introhive into three new industry segments: 1) Financial Services (Wealth Management and Insurance), 2…
Industrial Research Assistance Program Contribut… 2021-22 Nov. 1, 2021 - March 24, 2023
$6,670,000
Laurent Pharmaceuticals Inc. Montreal, QC
Clinical development of LAU-7b antiviral and inflammation-controlling therapy for COVID-19 infection.
Industrial Research Assistance Program Contribut… 2021-22 Oct. 1, 2020 - March 31, 2022
$6,425,932
COVID-19 VI Providence
Providence Therapeutics Holdings Inc. Calgary, AB
Providence Therapeutics, Canadas leading mRNA vaccine manufacture, is manufacturing an mRNA vaccine against COVID-19. The company is in the R&D phases to demonstrate the preclinical and clinical effi…
Industrial Research Assistance Program Contribut… 2021-22 Sept. 1, 2020 - July 30, 2021
$6,400,000
COVID-19 VI Providence
Providence Therapeutics Holdings Inc. Calgary, AB
Providence Therapeutics, Canadas leading mRNA vaccine manufacture, is manufacturing an mRNA vaccine against COVID-19. The company is in the R&D phases to demonstrate the preclinical and clinical effi…
Industrial Research Assistance Program Contribut… 2021-22 Sept. 1, 2020 - July 30, 2021
$6,400,000
In-Sec-M Cyber security services to SMEs
In-Sec-M, Security Research and Innovation Gatineau, QC
The project aims to support and increase the cyber security posture of innovative Canadian SMEs of all sector of activities that requires diligence in their day-to-day activities as well as when deve…
Industrial Research Assistance Program Contribut… 2021-22 April 5, 2020 - March 31, 2023
$6,370,000
AbCellera Biologics Inc. Vancouver, BC
Identify and develop antibody therapeutics for response and preparedness against COVID-19, and expand capacity for rapid development and delivery of antibody therapeutics.
Industrial Research Assistance Program Contribut… 2023-24 Nov. 1, 2022 - March 31, 2024
$6,325,000
Saltworks Technologies Inc. Richmond, BC
The project will develop sustainable and economic lithium processing technology that will contribute to addressing lithium supply challenges. Battery-grade lithium is a critical component of batterie…
Industrial Research Assistance Program Contribut… 2023-24 Oct. 1, 2023 - Sept. 30, 2026
$6,200,000
Greater Toronto Airports Authority Toronto, ON
The GTAA will evaluate various SARS-CoV-2 diagnostic tests of domestic and international passengers on arrival and departure including airport employees and various high touch surfaces used by passen…
Industrial Research Assistance Program Contribut… 2021-22 Nov. 23, 2020 - July 31, 2022
$6,097,280
Greater Toronto Airports Authority Toronto, ON
The GTAA will evaluate various SARS-CoV-2 diagnostic tests of domestic and international passengers on arrival and departure including airport employees and various high touch surfaces used by passen…
Industrial Research Assistance Program Contribut… 2021-22 Nov. 23, 2020 - March 31, 2022
$6,097,280
Avidbots Corp. Kitchener, ON
Avidbots has ambitious growth goals in 2024 and we plan to run a series of R&D and Business Innovation projects to accomplish them. Both the technical and business innovations in this project will he…
Industrial Research Assistance Program Contribut… 2023-24 Aug. 1, 2023 - Sept. 30, 2024
$6,013,020
Corvus Energy Inc. Richmond, BC
Develop and test multi-megawatt, modular, compact energy storage systems with multi-layered fully integrated controls and management information system for marine applications.
Industrial Research Assistance Program Contribut… 2021-22 Oct. 1, 2019 - March 18, 2022
$6,000,000
ImmunoVaccine Technologies Inc. Dartmouth, NS
In response to the global crisis, IMV has initiated the development of a vaccine to protect against the COVID-19 pandemic. We believe our targeted peptide epitope approach has the potential to optimi…
Industrial Research Assistance Program Contribut… 2021-22 Sept. 4, 2020 - March 31, 2022
$5,887,037
ImmunoVaccine Technologies Inc. Dartmouth, NS
In response to the global crisis, IMV has initiated the development of a vaccine to protect against the COVID-19 pandemic. We believe our targeted peptide epitope approach has the potential to optimi…
Industrial Research Assistance Program ? Contribu… 2020-21 Sept. 4, 2020 - Sept. 30, 2021
$5,887,037
Corporation inno-Centre du Qubec Montreal, QC
Dmarcher, slectionner et encadrer des entreprises technologiques en dmarrage fort potentiel commercial, ayant atteint le stade de la commercialisation ou devant latteindre rapidement, de sorte quell…
Canada Accelerator and Incubator Program 2018-19 June 1, 2014 - March 31, 2019
$5,850,584
Greater Toronto Airports Authority Toronto, ON
The GTAA will evaluate various SARS-CoV-2 diagnostic tests of domestic and international passengers on arrival and departure including airport employees and various high touch surfaces used by passen…
Industrial Research Assistance Program Contribut… 2021-22 Nov. 23, 2020 - Sept. 30, 2021
$5,690,280
Pharma Glycovax Inc Montreal, QC
Using O-glycan biomarkers, a vaccine against Covid-19 virus will be confirmed as non-toxic and then tested at the clinical level (phase I).
Industrial Research Assistance Program Contribut… 2021-22 Aug. 31, 2020 - July 16, 2022
$5,612,600
New Robotic Platform for Medical Purpose
Kinova inc Boisbriand, QC
The development and deployment of robotic solutions remain a major challenge for most companies, regardless of the markets. Kinova intends to address this challenge by developing a modular robotic pl…
Industrial Research Assistance Program Contribut… 2023-24 Sept. 18, 2023 - March 31, 2026
$5,600,000
Corvus Energy Inc. Richmond, BC
Develop and test multi-megawatt, modular, compact energy storage systems with multi-layered fully integrated controls and management information system for marine applications.
Industrial Research Assistance Program ? Contribu… 2020-21 Oct. 1, 2019 - March 18, 2022
$5,600,000
Pharma Glycovax Inc Montreal, QC
Using O-glycan biomarkers, a vaccine against Covid-19 virus will be confirmed as non-toxic and then tested at the clinical level (phase I).
Industrial Research Assistance Program Contribut… 2021-22 Aug. 31, 2020 - March 15, 2022
$5,552,600
Qu Biologics Inc. Burnaby, BC
#######################################################################################################################################################################################################…
Industrial Research Assistance Program Contribut… 2023-24 Sept. 1, 2022 - March 31, 2024
$5,426,172
ImmunoVaccine Technologies Inc. Dartmouth, NS
In response to the global crisis, IMV has initiated the development of a vaccine to protect against the COVID-19 pandemic. We believe our targeted peptide epitope approach has the potential to optimi…
Industrial Research Assistance Program ? Contribu… 2020-21 Sept. 4, 2020 - March 31, 2021
$5,412,045
Digital Fraud Detection and Risk Scoring Product
Trulioo Information Services Inc. Vancouver, BC
Software development project to develop a new digital product that will provide an instantaneous first assessment of potential fraud with an associated risk score for individuals or businesses signin…
Industrial Research Assistance Program Contribut… 2023-24 April 1, 2022 - Sept. 30, 2024
$5,229,998
Entos Pharmaceuticals Inc. Edmonton, AB
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 infection by SARS-CoV-2. In this project, Entos will advance the VAX-001 vaccin…
Industrial Research Assistance Program Contribut… 2021-22 Nov. 1, 2021 - Dec. 31, 2022
$5,200,000
Entos Pharmaceuticals Inc. Edmonton, AB
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 infection by SARS-CoV-2. In this project, Entos will advance the VAX-001 vaccin…
Industrial Research Assistance Program Contribut… 2021-22 Nov. 1, 2021 - March 31, 2022
$5,200,000
Entos Pharmaceuticals Inc. Edmonton, AB
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 infection by SARS-CoV-2. In this project, Entos will advance the VAX-001 vaccin…
Industrial Research Assistance Program ? Contribu… 2020-21 Sept. 1, 2020 - May 31, 2021
$5,200,000
Greater Toronto Airports Authority Toronto, ON
The GTAA will evaluate various SARS-CoV-2 diagnostic tests of domestic and international passengers on arrival and departure including airport employees and various high touch surfaces used by passen…
Industrial Research Assistance Program ? Contribu… 2020-21 Nov. 23, 2020 - July 31, 2021
$5,190,280
Interactive Visits at Technology Access Centres
Tech-Access Canada Ottawa, ON
Tech-Access Canada will deliver an Interactive Visit program to enable SMEs to access the specialized innovation services of a Technology Access Centre. SMEs will receive 20 hrs of technical assistan…
Industrial Research Assistance Program Contribut… 2021-22 April 1, 2021 - March 31, 2023
$5,155,000
Entos Pharmaceuticals Inc. Edmonton, AB
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 infection by SARS-CoV-2. In this project, Entos will advance the VAX-001 vaccin…
Industrial Research Assistance Program ? Contribu… 2020-21 Sept. 1, 2020 - March 31, 2021
$5,000,000
COVID-19 VI Providence
Providence Therapeutics Holdings Inc. Calgary, AB
Providence Therapeutics, Canada?s leading mRNA vaccine manufacture, is manufacturing an mRNA vaccine against COVID-19. The company is in the R&D phases to demonstrate the preclinical and clinical eff…
Industrial Research Assistance Program ? Contribu… 2020-21 Sept. 1, 2020 - Aug. 31, 2021
$4,700,000
JN NOVA PHARMA INC Montreal, QC
Development of a proprietary biological drug to block Coronavirus infectivity, whilst reducing induced pathology in symptomatic patients, permitting a faster recovery and avoiding multiple organ inju…
Industrial Research Assistance Program Contribut… 2021-22 Oct. 5, 2020 - Jan. 31, 2023
$4,609,000
JN NOVA PHARMA INC Montreal, QC
Development of a proprietary biological drug to block Coronavirus infectivity, whilst reducing induced pathology in symptomatic patients, permitting a faster recovery and avoiding multiple organ inju…
Industrial Research Assistance Program Contribut… 2021-22 Oct. 5, 2020 - March 31, 2022
$4,609,000
JN NOVA PHARMA INC Montreal, QC
Development of a proprietary biological drug to block Coronavirus infectivity, whilst reducing induced pathology in symptomatic patients, permitting a faster recovery and avoiding multiple organ inju…
Industrial Research Assistance Program ? Contribu… 2020-21 Oct. 5, 2020 - Nov. 26, 2021
$4,609,000
Symvivo Corporation Burnaby, BC
This project will involve further development and characterization of oral bacTRL-based vaccines. This work includes the preclinical development of additional bacTRL-based products including emergen…
Industrial Research Assistance Program Contribut… 2021-22 June 1, 2021 - June 30, 2022
$4,571,774
Symvivo Corporation Burnaby, BC
This project will involve further development and characterization of oral bacTRL-based vaccines. This work includes the preclinical development of additional bacTRL-based products including emergen…
Industrial Research Assistance Program Contribut… 2021-22 June 1, 2021 - March 18, 2022
$4,571,774
Laurent Pharmaceuticals Inc. Montreal, QC
Clinical development of LAU-7b antiviral and inflammation-controlling therapy for COVID-19 infection.
Industrial Research Assistance Program ? Contribu… 2020-21 Oct. 1, 2020 - Sept. 30, 2021
$4,166,796
Arch Biopartners Inc. Toronto, ON
The project targets the prevention of acute organ inflammation injury in the lungs and kidneys of patients who have moderate to severe COVID-19 and other diseases. LSALT peptide is a novel drug candi…
Industrial Research Assistance Program Contribut… 2023-24 Nov. 1, 2022 - March 31, 2024
$4,000,000
Transformational Financial Crime Detection
Verafin Solutions ULC St. John's, NL
Verafin will transform the financial crime detection industry by utilizing new technologies in our cloud environment to help the Firm design, develop, test, and deliver innovative Financial Crime Man…
Industrial Research Assistance Program Contribut… 2021-22 Oct. 28, 2019 - Oct. 31, 2022